What ICH E2E Pharmacovigilance Planning & Global Pharmacovigilance Obligations (2026) requires
ICH E2E and related guidelines establish international standards for pharmacovigilance planning, risk management plans (RMPs), signal detection, periodic benefit-risk evaluation reports (PBRERs), and post-authorisation safety studies. Manufacturers and marketing authorisation holders must maintain robust pharmacovigilance systems, including global safety databases and timely reporting of adverse events.
Pillar: Medical & Healthcare · Authority: International Council for Harmonisation (ICH) + Regional Authorities (FDA, EMA, PMDA, etc.) · Version: 1.0.0 · Last updated:
Primary source: https://ich.org/page/efficacy-guidelines
SHA-256 integrity: 21aeece30aef8de8766d63236e24b652b2222e26d05b6b5b60b51ce2c0ec7ad3
Primary Citations — 4 traced to source
- ICH E2E Pharmacovigilance Planning
- ICH E2F Development Safety Update Report
+ 2 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/pharmacovigilance-ich-e2e-2026.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/pharmacovigilance-ich-e2e-2026.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/pharmacovigilance-ich-e2e-2026
- Back to registry: Browse all 10,090 compliance nodes